id	sid	tid	token	lemma	pos
cord-340474-hbcu72cm	1	1	key	key	NN
cord-340474-hbcu72cm	1	2	:	:	:
cord-340474-hbcu72cm	2	1	cord-340474-hbcu72	cord-340474-hbcu72	NNP
cord-340474-hbcu72cm	2	2	cm	cm	NNS
cord-340474-hbcu72cm	2	3	authors	author	NNS
cord-340474-hbcu72cm	2	4	:	:	:
cord-340474-hbcu72cm	2	5	Kaushik	Kaushik	NNP
cord-340474-hbcu72cm	2	6	,	,	,
cord-340474-hbcu72cm	2	7	Akanksha	Akanksha	NNP
cord-340474-hbcu72cm	2	8	;	;	:
cord-340474-hbcu72cm	2	9	Parsad	Parsad	NNP
cord-340474-hbcu72cm	2	10	,	,	,
cord-340474-hbcu72cm	2	11	Davinder	Davinder	NNP
cord-340474-hbcu72cm	2	12	;	;	:
cord-340474-hbcu72cm	2	13	Kumaran	Kumaran	NNP
cord-340474-hbcu72cm	2	14	,	,	,
cord-340474-hbcu72cm	3	1	Muthu	Muthu	NNP
cord-340474-hbcu72cm	3	2	Sendhil	Sendhil	NNP
cord-340474-hbcu72cm	3	3	title	title	NN
cord-340474-hbcu72cm	3	4	:	:	:
cord-340474-hbcu72cm	3	5	Urticaria	urticaria	NN
cord-340474-hbcu72cm	3	6	in	in	IN
cord-340474-hbcu72cm	3	7	the	the	DT
cord-340474-hbcu72cm	3	8	times	time	NNS
cord-340474-hbcu72cm	3	9	of	of	IN
cord-340474-hbcu72cm	3	10	COVID‐19	COVID‐19	NNP
cord-340474-hbcu72cm	3	11	date	date	NN
cord-340474-hbcu72cm	3	12	:	:	:
cord-340474-hbcu72cm	3	13	2020	2020	CD
cord-340474-hbcu72cm	3	14	-	-	HYPH
cord-340474-hbcu72cm	3	15	06	06	CD
cord-340474-hbcu72cm	3	16	-	-	SYM
cord-340474-hbcu72cm	3	17	12	12	CD
cord-340474-hbcu72cm	3	18	journal	journal	NN
cord-340474-hbcu72cm	3	19	:	:	:
cord-340474-hbcu72cm	4	1	Dermatol	Dermatol	NNP
cord-340474-hbcu72cm	5	1	Ther	ther	JJ
cord-340474-hbcu72cm	5	2	DOI	DOI	NNP
cord-340474-hbcu72cm	5	3	:	:	:
cord-340474-hbcu72cm	6	1	10.1111	10.1111	CD
cord-340474-hbcu72cm	6	2	/	/	SYM
cord-340474-hbcu72cm	6	3	dth.13817	dth.13817	NN
cord-340474-hbcu72cm	7	1	sha	sha	NNP
cord-340474-hbcu72cm	7	2	:	:	:
cord-340474-hbcu72cm	7	3	b96c6dde300db2d5095948da748e97d6ad7e4527	b96c6dde300db2d5095948da748e97d6ad7e4527	NNP
cord-340474-hbcu72cm	7	4	doc_id	doc_id	NNPS
cord-340474-hbcu72cm	7	5	:	:	:
cord-340474-hbcu72cm	7	6	340474	340474	CD
cord-340474-hbcu72cm	7	7	cord_uid	cord_uid	NNS
cord-340474-hbcu72cm	7	8	:	:	:
cord-340474-hbcu72cm	7	9	hbcu72	hbcu72	NNP
cord-340474-hbcu72cm	7	10	cm	cm	NNP
cord-340474-hbcu72cm	8	1	nan	nan	NNP
cord-340474-hbcu72cm	8	2	morbidity	morbidity	NNP
cord-340474-hbcu72cm	8	3	and	and	CC
cord-340474-hbcu72cm	8	4	severe	severe	JJ
cord-340474-hbcu72cm	8	5	economic	economic	JJ
cord-340474-hbcu72cm	8	6	disruptions	disruption	NNS
cord-340474-hbcu72cm	8	7	in	in	IN
cord-340474-hbcu72cm	8	8	recent	recent	JJ
cord-340474-hbcu72cm	8	9	times	time	NNS
cord-340474-hbcu72cm	8	10	.	.	.
cord-340474-hbcu72cm	9	1	Of	of	IN
cord-340474-hbcu72cm	9	2	late	late	RB
cord-340474-hbcu72cm	9	3	,	,	,
cord-340474-hbcu72cm	9	4	there	there	EX
cord-340474-hbcu72cm	9	5	has	have	VBZ
cord-340474-hbcu72cm	9	6	been	be	VBN
cord-340474-hbcu72cm	9	7	a	a	DT
cord-340474-hbcu72cm	9	8	growing	grow	VBG
cord-340474-hbcu72cm	9	9	interest	interest	NN
cord-340474-hbcu72cm	9	10	regarding	regard	VBG
cord-340474-hbcu72cm	9	11	the	the	DT
cord-340474-hbcu72cm	9	12	dermatological	dermatological	JJ
cord-340474-hbcu72cm	9	13	manifestations	manifestation	NNS
cord-340474-hbcu72cm	9	14	in	in	IN
cord-340474-hbcu72cm	9	15	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	9	16	.	.	.
cord-340474-hbcu72cm	10	1	In	in	IN
cord-340474-hbcu72cm	10	2	an	an	DT
cord-340474-hbcu72cm	10	3	early	early	JJ
cord-340474-hbcu72cm	10	4	retrospective	retrospective	JJ
cord-340474-hbcu72cm	10	5	study	study	NN
cord-340474-hbcu72cm	10	6	among	among	IN
cord-340474-hbcu72cm	10	7	140	140	CD
cord-340474-hbcu72cm	10	8	patients	patient	NNS
cord-340474-hbcu72cm	10	9	Zhang	Zhang	NNP
cord-340474-hbcu72cm	10	10	et	et	NNP
cord-340474-hbcu72cm	10	11	al	al	NNP
cord-340474-hbcu72cm	10	12	1	1	CD
cord-340474-hbcu72cm	10	13	reported	report	VBD
cord-340474-hbcu72cm	10	14	11.4	11.4	CD
cord-340474-hbcu72cm	10	15	%	%	NN
cord-340474-hbcu72cm	10	16	patients	patient	NNS
cord-340474-hbcu72cm	10	17	to	to	TO
cord-340474-hbcu72cm	10	18	have	have	VB
cord-340474-hbcu72cm	10	19	drug	drug	NN
cord-340474-hbcu72cm	10	20	hypersensitivity	hypersensitivity	NN
cord-340474-hbcu72cm	10	21	and	and	CC
cord-340474-hbcu72cm	10	22	1.4	1.4	CD
cord-340474-hbcu72cm	10	23	%	%	NN
cord-340474-hbcu72cm	10	24	to	to	TO
cord-340474-hbcu72cm	10	25	have	have	VB
cord-340474-hbcu72cm	10	26	urticaria	urticaria	NN
cord-340474-hbcu72cm	10	27	.	.	.
cord-340474-hbcu72cm	11	1	In	in	IN
cord-340474-hbcu72cm	11	2	a	a	DT
cord-340474-hbcu72cm	11	3	report	report	NN
cord-340474-hbcu72cm	11	4	from	from	IN
cord-340474-hbcu72cm	11	5	Italy	Italy	NNP
cord-340474-hbcu72cm	11	6	,	,	,
cord-340474-hbcu72cm	11	7	18/88	18/88	CD
cord-340474-hbcu72cm	11	8	(	(	-LRB-
cord-340474-hbcu72cm	11	9	20.5	20.5	CD
cord-340474-hbcu72cm	11	10	%	%	NN
cord-340474-hbcu72cm	11	11	)	)	-RRB-
cord-340474-hbcu72cm	11	12	patients	patient	NNS
cord-340474-hbcu72cm	11	13	had	have	VBD
cord-340474-hbcu72cm	11	14	dermatological	dermatological	JJ
cord-340474-hbcu72cm	11	15	manifestations	manifestation	NNS
cord-340474-hbcu72cm	11	16	,	,	,
cord-340474-hbcu72cm	11	17	with	with	IN
cord-340474-hbcu72cm	11	18	3	3	CD
cord-340474-hbcu72cm	11	19	patients	patient	NNS
cord-340474-hbcu72cm	11	20	reporting	report	VBG
cord-340474-hbcu72cm	11	21	widespread	widespread	JJ
cord-340474-hbcu72cm	11	22	urticaria	urticaria	NN
cord-340474-hbcu72cm	11	23	.	.	.
cord-340474-hbcu72cm	12	1	2	2	LS
cord-340474-hbcu72cm	13	1	As	as	IN
cord-340474-hbcu72cm	13	2	per	per	IN
cord-340474-hbcu72cm	13	3	one	one	CD
cord-340474-hbcu72cm	13	4	review	review	NN
cord-340474-hbcu72cm	13	5	,	,	,
cord-340474-hbcu72cm	13	6	88/256	88/256	CD
cord-340474-hbcu72cm	13	7	(	(	-LRB-
cord-340474-hbcu72cm	13	8	34.3	34.3	CD
cord-340474-hbcu72cm	13	9	%	%	NN
cord-340474-hbcu72cm	13	10	)	)	-RRB-
cord-340474-hbcu72cm	14	1	patients	patient	NNS
cord-340474-hbcu72cm	14	2	across	across	IN
cord-340474-hbcu72cm	14	3	16	16	CD
cord-340474-hbcu72cm	14	4	studies	study	NNS
cord-340474-hbcu72cm	14	5	demonstrated	demonstrate	VBD
cord-340474-hbcu72cm	14	6	skin	skin	NN
cord-340474-hbcu72cm	14	7	manifestations	manifestation	NNS
cord-340474-hbcu72cm	14	8	,	,	,
cord-340474-hbcu72cm	14	9	mostly	mostly	RB
cord-340474-hbcu72cm	14	10	as	as	IN
cord-340474-hbcu72cm	14	11	erythematous	erythematous	JJ
cord-340474-hbcu72cm	14	12	maculopapular	maculopapular	JJ
cord-340474-hbcu72cm	14	13	rash	rash	JJ
cord-340474-hbcu72cm	14	14	,	,	,
cord-340474-hbcu72cm	14	15	urticaria	urticaria	NN
cord-340474-hbcu72cm	14	16	or	or	CC
cord-340474-hbcu72cm	14	17	vesicular	vesicular	JJ
cord-340474-hbcu72cm	14	18	rash	rash	NN
cord-340474-hbcu72cm	14	19	.	.	.
cord-340474-hbcu72cm	15	1	3	3	LS
cord-340474-hbcu72cm	16	1	On	on	IN
cord-340474-hbcu72cm	16	2	closer	close	JJR
cord-340474-hbcu72cm	16	3	look	look	NN
cord-340474-hbcu72cm	16	4	,	,	,
cord-340474-hbcu72cm	16	5	we	-PRON-	PRP
cord-340474-hbcu72cm	16	6	find	find	VBP
cord-340474-hbcu72cm	16	7	urticaria	urticaria	NN
cord-340474-hbcu72cm	16	8	to	to	TO
cord-340474-hbcu72cm	16	9	be	be	VB
cord-340474-hbcu72cm	16	10	a	a	DT
cord-340474-hbcu72cm	16	11	commonly	commonly	RB
cord-340474-hbcu72cm	16	12	reported	report	VBN
cord-340474-hbcu72cm	16	13	finding	finding	NN
cord-340474-hbcu72cm	16	14	among	among	IN
cord-340474-hbcu72cm	16	15	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	16	16	patients	patient	NNS
cord-340474-hbcu72cm	16	17	.	.	.
cord-340474-hbcu72cm	17	1	In	in	IN
cord-340474-hbcu72cm	17	2	one	one	CD
cord-340474-hbcu72cm	17	3	of	of	IN
cord-340474-hbcu72cm	17	4	the	the	DT
cord-340474-hbcu72cm	17	5	large	large	JJ
cord-340474-hbcu72cm	17	6	prospective	prospective	JJ
cord-340474-hbcu72cm	17	7	studies	study	NNS
cord-340474-hbcu72cm	17	8	involving	involve	VBG
cord-340474-hbcu72cm	17	9	375	375	CD
cord-340474-hbcu72cm	17	10	COVID	covid	JJ
cord-340474-hbcu72cm	17	11	19	19	CD
cord-340474-hbcu72cm	17	12	cases	case	NNS
cord-340474-hbcu72cm	17	13	,	,	,
cord-340474-hbcu72cm	17	14	urticaria	urticaria	NN
cord-340474-hbcu72cm	17	15	was	be	VBD
cord-340474-hbcu72cm	17	16	present	present	JJ
cord-340474-hbcu72cm	17	17	in	in	IN
cord-340474-hbcu72cm	17	18	19	19	CD
cord-340474-hbcu72cm	17	19	%	%	NN
cord-340474-hbcu72cm	17	20	cases	case	NNS
cord-340474-hbcu72cm	17	21	,	,	,
cord-340474-hbcu72cm	17	22	with	with	IN
cord-340474-hbcu72cm	17	23	mean	mean	JJ
cord-340474-hbcu72cm	17	24	duration	duration	NN
cord-340474-hbcu72cm	17	25	of	of	IN
cord-340474-hbcu72cm	17	26	urticaria	urticaria	NN
cord-340474-hbcu72cm	17	27	being	be	VBG
cord-340474-hbcu72cm	17	28	6.8	6.8	CD
cord-340474-hbcu72cm	17	29	days	day	NNS
cord-340474-hbcu72cm	17	30	.	.	.
cord-340474-hbcu72cm	18	1	4	4	LS
cord-340474-hbcu72cm	19	1	While	while	IN
cord-340474-hbcu72cm	19	2	there	there	EX
cord-340474-hbcu72cm	19	3	was	be	VBD
cord-340474-hbcu72cm	19	4	a	a	DT
cord-340474-hbcu72cm	19	5	report	report	NN
cord-340474-hbcu72cm	19	6	of	of	IN
cord-340474-hbcu72cm	19	7	one	one	CD
cord-340474-hbcu72cm	20	1	COVID-19	covid-19	JJ
cord-340474-hbcu72cm	20	2	patient	patient	NN
cord-340474-hbcu72cm	20	3	presenting	present	VBG
cord-340474-hbcu72cm	20	4	with	with	IN
cord-340474-hbcu72cm	20	5	urticaria	urticaria	NN
cord-340474-hbcu72cm	20	6	and	and	CC
cord-340474-hbcu72cm	20	7	dry	dry	JJ
cord-340474-hbcu72cm	20	8	cough	cough	NN
cord-340474-hbcu72cm	20	9	without	without	IN
cord-340474-hbcu72cm	20	10	any	any	DT
cord-340474-hbcu72cm	20	11	fever	fever	NN
cord-340474-hbcu72cm	20	12	,	,	,
cord-340474-hbcu72cm	20	13	5	5	CD
cord-340474-hbcu72cm	20	14	the	the	DT
cord-340474-hbcu72cm	20	15	timing	timing	NN
cord-340474-hbcu72cm	20	16	of	of	IN
cord-340474-hbcu72cm	20	17	appearance	appearance	NN
cord-340474-hbcu72cm	20	18	of	of	IN
cord-340474-hbcu72cm	20	19	urticaria	urticaria	NN
cord-340474-hbcu72cm	20	20	was	be	VBD
cord-340474-hbcu72cm	20	21	variable	variable	JJ
cord-340474-hbcu72cm	20	22	,	,	,
cord-340474-hbcu72cm	20	23	with	with	IN
cord-340474-hbcu72cm	20	24	lesions	lesion	NNS
cord-340474-hbcu72cm	20	25	appearing	appear	VBG
cord-340474-hbcu72cm	20	26	before	before	RB
cord-340474-hbcu72cm	20	27	,	,	,
cord-340474-hbcu72cm	20	28	with	with	IN
cord-340474-hbcu72cm	20	29	,	,	,
cord-340474-hbcu72cm	20	30	as	as	RB
cord-340474-hbcu72cm	20	31	well	well	RB
cord-340474-hbcu72cm	20	32	as	as	IN
cord-340474-hbcu72cm	20	33	>	>	$
cord-340474-hbcu72cm	20	34	48	48	CD
cord-340474-hbcu72cm	20	35	hours	hour	NNS
cord-340474-hbcu72cm	20	36	after	after	IN
cord-340474-hbcu72cm	20	37	onset	onset	NN
cord-340474-hbcu72cm	20	38	of	of	IN
cord-340474-hbcu72cm	20	39	fever	fever	NN
cord-340474-hbcu72cm	20	40	.	.	.
cord-340474-hbcu72cm	21	1	[	[	-LRB-
cord-340474-hbcu72cm	21	2	6	6	CD
cord-340474-hbcu72cm	21	3	]	]	-RRB-
cord-340474-hbcu72cm	21	4	[	[	-LRB-
cord-340474-hbcu72cm	21	5	7	7	CD
cord-340474-hbcu72cm	21	6	]	]	-RRB-
cord-340474-hbcu72cm	21	7	[	[	-LRB-
cord-340474-hbcu72cm	21	8	8	8	CD
cord-340474-hbcu72cm	21	9	]	]	-RRB-
cord-340474-hbcu72cm	21	10	[	[	-LRB-
cord-340474-hbcu72cm	21	11	9	9	CD
cord-340474-hbcu72cm	21	12	]	]	-RRB-
cord-340474-hbcu72cm	22	1	In	in	IN
cord-340474-hbcu72cm	22	2	most	most	JJS
cord-340474-hbcu72cm	22	3	cases	case	NNS
cord-340474-hbcu72cm	22	4	,	,	,
cord-340474-hbcu72cm	22	5	diagnosis	diagnosis	NN
cord-340474-hbcu72cm	22	6	of	of	IN
cord-340474-hbcu72cm	22	7	urticaria	urticaria	NN
cord-340474-hbcu72cm	22	8	was	be	VBD
cord-340474-hbcu72cm	22	9	made	make	VBN
cord-340474-hbcu72cm	22	10	clinically	clinically	JJ
cord-340474-hbcu72cm	22	11	and	and	CC
cord-340474-hbcu72cm	22	12	oral	oral	JJ
cord-340474-hbcu72cm	22	13	2	2	CD
cord-340474-hbcu72cm	22	14	nd	nd	NNP
cord-340474-hbcu72cm	22	15	generation	generation	NN
cord-340474-hbcu72cm	22	16	antihistamines	antihistamine	NNS
cord-340474-hbcu72cm	22	17	were	be	VBD
cord-340474-hbcu72cm	22	18	prescribed	prescribe	VBN
cord-340474-hbcu72cm	22	19	with	with	IN
cord-340474-hbcu72cm	22	20	satisfactory	satisfactory	JJ
cord-340474-hbcu72cm	22	21	results	result	NNS
cord-340474-hbcu72cm	22	22	.	.	.
cord-340474-hbcu72cm	23	1	[	[	-LRB-
cord-340474-hbcu72cm	23	2	6	6	CD
cord-340474-hbcu72cm	23	3	]	]	-RRB-
cord-340474-hbcu72cm	23	4	[	[	-LRB-
cord-340474-hbcu72cm	23	5	7	7	CD
cord-340474-hbcu72cm	23	6	]	]	-RRB-
cord-340474-hbcu72cm	23	7	[	[	-LRB-
cord-340474-hbcu72cm	23	8	8	8	CD
cord-340474-hbcu72cm	23	9	]	]	-RRB-
cord-340474-hbcu72cm	24	1	[	[	-LRB-
cord-340474-hbcu72cm	24	2	9	9	CD
cord-340474-hbcu72cm	24	3	]	]	-RRB-
cord-340474-hbcu72cm	25	1	Although	although	IN
cord-340474-hbcu72cm	25	2	skin	skin	NN
cord-340474-hbcu72cm	25	3	manifestations	manifestation	NNS
cord-340474-hbcu72cm	25	4	did	do	VBD
cord-340474-hbcu72cm	25	5	not	not	RB
cord-340474-hbcu72cm	25	6	correlate	correlate	VB
cord-340474-hbcu72cm	25	7	with	with	IN
cord-340474-hbcu72cm	25	8	disease	disease	NN
cord-340474-hbcu72cm	25	9	severity	severity	NN
cord-340474-hbcu72cm	25	10	in	in	IN
cord-340474-hbcu72cm	25	11	most	most	JJS
cord-340474-hbcu72cm	25	12	case	case	NN
cord-340474-hbcu72cm	25	13	reports	report	NNS
cord-340474-hbcu72cm	25	14	,	,	,
cord-340474-hbcu72cm	25	15	2,6	2,6	CD
cord-340474-hbcu72cm	26	1	the	the	DT
cord-340474-hbcu72cm	26	2	prospective	prospective	JJ
cord-340474-hbcu72cm	26	3	This	this	DT
cord-340474-hbcu72cm	26	4	article	article	NN
cord-340474-hbcu72cm	26	5	is	be	VBZ
cord-340474-hbcu72cm	26	6	protected	protect	VBN
cord-340474-hbcu72cm	26	7	by	by	IN
cord-340474-hbcu72cm	26	8	copyright	copyright	NN
cord-340474-hbcu72cm	26	9	.	.	.
cord-340474-hbcu72cm	27	1	All	all	DT
cord-340474-hbcu72cm	27	2	rights	right	NNS
cord-340474-hbcu72cm	27	3	reserved	reserve	VBN
cord-340474-hbcu72cm	27	4	.	.	.
cord-340474-hbcu72cm	28	1	study	study	NN
cord-340474-hbcu72cm	28	2	from	from	IN
cord-340474-hbcu72cm	28	3	Spain	Spain	NNP
cord-340474-hbcu72cm	28	4	suggested	suggest	VBD
cord-340474-hbcu72cm	28	5	that	that	IN
cord-340474-hbcu72cm	28	6	presence	presence	NN
cord-340474-hbcu72cm	28	7	of	of	IN
cord-340474-hbcu72cm	28	8	urticaria	urticaria	NN
cord-340474-hbcu72cm	28	9	and	and	CC
cord-340474-hbcu72cm	28	10	maculopapular	maculopapular	JJ
cord-340474-hbcu72cm	28	11	lesions	lesion	NNS
cord-340474-hbcu72cm	28	12	were	be	VBD
cord-340474-hbcu72cm	28	13	associated	associate	VBN
cord-340474-hbcu72cm	28	14	with	with	IN
cord-340474-hbcu72cm	28	15	more	more	JJR
cord-340474-hbcu72cm	28	16	severe	severe	JJ
cord-340474-hbcu72cm	28	17	COVID	covid	JJ
cord-340474-hbcu72cm	28	18	19	19	CD
cord-340474-hbcu72cm	28	19	illness	illness	NN
cord-340474-hbcu72cm	28	20	and	and	CC
cord-340474-hbcu72cm	28	21	a	a	DT
cord-340474-hbcu72cm	28	22	higher	high	JJR
cord-340474-hbcu72cm	28	23	(	(	-LRB-
cord-340474-hbcu72cm	28	24	2	2	CD
cord-340474-hbcu72cm	28	25	%	%	NN
cord-340474-hbcu72cm	28	26	)	)	-RRB-
cord-340474-hbcu72cm	28	27	mortality	mortality	NN
cord-340474-hbcu72cm	28	28	.	.	.
cord-340474-hbcu72cm	29	1	.	.	.
cord-340474-hbcu72cm	30	1	4	4	LS
cord-340474-hbcu72cm	30	2	Pathophysiology	pathophysiology	NN
cord-340474-hbcu72cm	30	3	of	of	IN
cord-340474-hbcu72cm	30	4	urticaria	urticaria	NN
cord-340474-hbcu72cm	30	5	in	in	IN
cord-340474-hbcu72cm	30	6	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	30	7	infection	infection	NN
cord-340474-hbcu72cm	30	8	is	be	VBZ
cord-340474-hbcu72cm	30	9	hypothesised	hypothesise	VBN
cord-340474-hbcu72cm	30	10	to	to	TO
cord-340474-hbcu72cm	30	11	be	be	VB
cord-340474-hbcu72cm	30	12	multifactorial	multifactorial	JJ
cord-340474-hbcu72cm	30	13	.	.	.
cord-340474-hbcu72cm	31	1	While	while	IN
cord-340474-hbcu72cm	31	2	drug	drug	NN
cord-340474-hbcu72cm	31	3	-	-	HYPH
cord-340474-hbcu72cm	31	4	induced	induce	VBN
cord-340474-hbcu72cm	31	5	urticaria	urticaria	NN
cord-340474-hbcu72cm	31	6	may	may	MD
cord-340474-hbcu72cm	31	7	be	be	VB
cord-340474-hbcu72cm	31	8	an	an	DT
cord-340474-hbcu72cm	31	9	obvious	obvious	JJ
cord-340474-hbcu72cm	31	10	explanation	explanation	NN
cord-340474-hbcu72cm	31	11	,	,	,
cord-340474-hbcu72cm	31	12	urticaria	urticaria	NN
cord-340474-hbcu72cm	31	13	preceded	precede	VBD
cord-340474-hbcu72cm	31	14	drug	drug	NN
cord-340474-hbcu72cm	31	15	therapy	therapy	NN
cord-340474-hbcu72cm	31	16	or	or	CC
cord-340474-hbcu72cm	31	17	showed	show	VBD
cord-340474-hbcu72cm	31	18	spontaneous	spontaneous	JJ
cord-340474-hbcu72cm	31	19	remission	remission	NN
cord-340474-hbcu72cm	31	20	despite	despite	IN
cord-340474-hbcu72cm	31	21	continuation	continuation	NN
cord-340474-hbcu72cm	31	22	of	of	IN
cord-340474-hbcu72cm	31	23	therapy	therapy	NN
cord-340474-hbcu72cm	31	24	for	for	IN
cord-340474-hbcu72cm	31	25	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	31	26	,	,	,
cord-340474-hbcu72cm	31	27	6	6	CD
cord-340474-hbcu72cm	31	28	With	with	IN
cord-340474-hbcu72cm	31	29	an	an	DT
cord-340474-hbcu72cm	31	30	ever	ever	RB
cord-340474-hbcu72cm	31	31	-	-	HYPH
cord-340474-hbcu72cm	31	32	rising	rise	VBG
cord-340474-hbcu72cm	31	33	number	number	NN
cord-340474-hbcu72cm	31	34	of	of	IN
cord-340474-hbcu72cm	31	35	patients	patient	NNS
cord-340474-hbcu72cm	31	36	,	,	,
cord-340474-hbcu72cm	31	37	it	-PRON-	PRP
cord-340474-hbcu72cm	31	38	is	be	VBZ
cord-340474-hbcu72cm	31	39	too	too	RB
cord-340474-hbcu72cm	31	40	early	early	JJ
cord-340474-hbcu72cm	31	41	to	to	TO
cord-340474-hbcu72cm	31	42	determine	determine	VB
cord-340474-hbcu72cm	31	43	a	a	DT
cord-340474-hbcu72cm	31	44	precise	precise	JJ
cord-340474-hbcu72cm	31	45	prevalence	prevalence	NN
cord-340474-hbcu72cm	31	46	of	of	IN
cord-340474-hbcu72cm	31	47	urticaria	urticaria	NN
cord-340474-hbcu72cm	31	48	in	in	IN
cord-340474-hbcu72cm	31	49	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	31	50	and	and	CC
cord-340474-hbcu72cm	31	51	full	full	JJ
cord-340474-hbcu72cm	31	52	understanding	understanding	NN
cord-340474-hbcu72cm	31	53	of	of	IN
cord-340474-hbcu72cm	31	54	pathophysiologic	pathophysiologic	NN
cord-340474-hbcu72cm	31	55	mechanisms	mechanism	NNS
cord-340474-hbcu72cm	31	56	may	may	MD
cord-340474-hbcu72cm	31	57	also	also	RB
cord-340474-hbcu72cm	31	58	take	take	VB
cord-340474-hbcu72cm	31	59	time	time	NN
cord-340474-hbcu72cm	31	60	.	.	.
cord-340474-hbcu72cm	32	1	With	with	IN
cord-340474-hbcu72cm	32	2	an	an	DT
cord-340474-hbcu72cm	32	3	eye	eye	NN
cord-340474-hbcu72cm	32	4	on	on	IN
cord-340474-hbcu72cm	32	5	the	the	DT
cord-340474-hbcu72cm	32	6	reported	report	VBN
cord-340474-hbcu72cm	32	7	literature	literature	NN
cord-340474-hbcu72cm	32	8	,	,	,
cord-340474-hbcu72cm	32	9	we	-PRON-	PRP
cord-340474-hbcu72cm	32	10	make	make	VBP
cord-340474-hbcu72cm	32	11	a	a	DT
cord-340474-hbcu72cm	32	12	few	few	JJ
cord-340474-hbcu72cm	32	13	suggestions	suggestion	NNS
cord-340474-hbcu72cm	32	14	regarding	regard	VBG
cord-340474-hbcu72cm	32	15	urticaria	urticaria	NN
cord-340474-hbcu72cm	32	16	in	in	IN
cord-340474-hbcu72cm	32	17	This	this	DT
cord-340474-hbcu72cm	32	18	article	article	NN
cord-340474-hbcu72cm	32	19	is	be	VBZ
cord-340474-hbcu72cm	32	20	protected	protect	VBN
cord-340474-hbcu72cm	32	21	by	by	IN
cord-340474-hbcu72cm	32	22	copyright	copyright	NN
cord-340474-hbcu72cm	32	23	.	.	.
cord-340474-hbcu72cm	33	1	All	all	DT
cord-340474-hbcu72cm	33	2	rights	right	NNS
cord-340474-hbcu72cm	33	3	reserved	reserve	VBN
cord-340474-hbcu72cm	33	4	.	.	.
cord-340474-hbcu72cm	34	1	(	(	-LRB-
cord-340474-hbcu72cm	34	2	Table	table	NN
cord-340474-hbcu72cm	34	3	1	1	CD
cord-340474-hbcu72cm	34	4	)	)	-RRB-
cord-340474-hbcu72cm	34	5	.	.	.
cord-340474-hbcu72cm	35	1	From	from	IN
cord-340474-hbcu72cm	35	2	management	management	NN
cord-340474-hbcu72cm	35	3	perspective	perspective	NN
cord-340474-hbcu72cm	35	4	,	,	,
cord-340474-hbcu72cm	35	5	oral	oral	JJ
cord-340474-hbcu72cm	35	6	2	2	CD
cord-340474-hbcu72cm	35	7	nd	nd	NNP
cord-340474-hbcu72cm	35	8	generation	generation	NN
cord-340474-hbcu72cm	35	9	antihistamines	antihistamine	NNS
cord-340474-hbcu72cm	35	10	seem	seem	VBP
cord-340474-hbcu72cm	35	11	to	to	TO
cord-340474-hbcu72cm	35	12	be	be	VB
cord-340474-hbcu72cm	35	13	an	an	DT
cord-340474-hbcu72cm	35	14	initial	initial	JJ
cord-340474-hbcu72cm	35	15	prudent	prudent	JJ
cord-340474-hbcu72cm	35	16	choice	choice	NN
cord-340474-hbcu72cm	35	17	.	.	.
cord-340474-hbcu72cm	36	1	Omalizumab	Omalizumab	NNP
cord-340474-hbcu72cm	36	2	can	can	MD
cord-340474-hbcu72cm	36	3	be	be	VB
cord-340474-hbcu72cm	36	4	used	use	VBN
cord-340474-hbcu72cm	36	5	in	in	IN
cord-340474-hbcu72cm	36	6	refractory	refractory	JJ
cord-340474-hbcu72cm	36	7	patients	patient	NNS
cord-340474-hbcu72cm	36	8	,	,	,
cord-340474-hbcu72cm	36	9	with	with	IN
cord-340474-hbcu72cm	36	10	the	the	DT
cord-340474-hbcu72cm	36	11	first	first	JJ
cord-340474-hbcu72cm	36	12	two	two	CD
cord-340474-hbcu72cm	36	13	doses	dose	NNS
cord-340474-hbcu72cm	36	14	being	be	VBG
cord-340474-hbcu72cm	36	15	given	give	VBN
cord-340474-hbcu72cm	36	16	in	in	IN
cord-340474-hbcu72cm	36	17	a	a	DT
cord-340474-hbcu72cm	36	18	hospital	hospital	NN
cord-340474-hbcu72cm	36	19	setting	set	VBG
cord-340474-hbcu72cm	36	20	as	as	IN
cord-340474-hbcu72cm	36	21	per	per	IN
cord-340474-hbcu72cm	36	22	a	a	DT
cord-340474-hbcu72cm	36	23	recent	recent	JJ
cord-340474-hbcu72cm	36	24	guidance	guidance	NN
cord-340474-hbcu72cm	36	25	summary	summary	NN
cord-340474-hbcu72cm	36	26	.	.	.
cord-340474-hbcu72cm	37	1	11	11	CD
cord-340474-hbcu72cm	37	2	We	-PRON-	PRP
cord-340474-hbcu72cm	37	3	reiterate	reiterate	VBP
cord-340474-hbcu72cm	37	4	that	that	IN
cord-340474-hbcu72cm	37	5	data	datum	NNS
cord-340474-hbcu72cm	37	6	so	so	RB
cord-340474-hbcu72cm	37	7	far	far	RB
cord-340474-hbcu72cm	37	8	is	be	VBZ
cord-340474-hbcu72cm	37	9	relatively	relatively	RB
cord-340474-hbcu72cm	37	10	sparse	sparse	JJ
cord-340474-hbcu72cm	37	11	and	and	CC
cord-340474-hbcu72cm	37	12	at	at	IN
cord-340474-hbcu72cm	37	13	times	time	NNS
cord-340474-hbcu72cm	37	14	,	,	,
cord-340474-hbcu72cm	37	15	incomparable	incomparable	JJ
cord-340474-hbcu72cm	37	16	.	.	.
cord-340474-hbcu72cm	38	1	As	as	IN
cord-340474-hbcu72cm	38	2	more	more	JJR
cord-340474-hbcu72cm	38	3	studies	study	NNS
cord-340474-hbcu72cm	38	4	are	be	VBP
cord-340474-hbcu72cm	38	5	performed	perform	VBN
cord-340474-hbcu72cm	38	6	,	,	,
cord-340474-hbcu72cm	38	7	medical	medical	JJ
cord-340474-hbcu72cm	38	8	science	science	NN
cord-340474-hbcu72cm	38	9	would	would	MD
cord-340474-hbcu72cm	38	10	be	be	VB
cord-340474-hbcu72cm	38	11	in	in	IN
cord-340474-hbcu72cm	38	12	a	a	DT
cord-340474-hbcu72cm	38	13	better	well	JJR
cord-340474-hbcu72cm	38	14	position	position	NN
cord-340474-hbcu72cm	38	15	to	to	TO
cord-340474-hbcu72cm	38	16	elucidate	elucidate	VB
cord-340474-hbcu72cm	38	17	the	the	DT
cord-340474-hbcu72cm	38	18	conundrum	conundrum	NN
cord-340474-hbcu72cm	38	19	of	of	IN
cord-340474-hbcu72cm	38	20	urticaria	urticaria	NN
cord-340474-hbcu72cm	38	21	in	in	IN
cord-340474-hbcu72cm	38	22	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	38	23	.	.	.
cord-340474-hbcu72cm	39	1	Clinical	clinical	JJ
cord-340474-hbcu72cm	39	2	characteristics	characteristic	NNS
cord-340474-hbcu72cm	39	3	of	of	IN
cord-340474-hbcu72cm	39	4	140	140	CD
cord-340474-hbcu72cm	39	5	patients	patient	NNS
cord-340474-hbcu72cm	39	6	infected	infect	VBN
cord-340474-hbcu72cm	39	7	with	with	IN
cord-340474-hbcu72cm	39	8	SARS	SARS	NNP
cord-340474-hbcu72cm	39	9	-	-	HYPH
cord-340474-hbcu72cm	39	10	CoV-2	CoV-2	NNP
cord-340474-hbcu72cm	39	11	in	in	IN
cord-340474-hbcu72cm	39	12	Wuhan	Wuhan	NNP
cord-340474-hbcu72cm	39	13	Cutaneous	cutaneous	JJ
cord-340474-hbcu72cm	39	14	manifestations	manifestation	NNS
cord-340474-hbcu72cm	39	15	in	in	IN
cord-340474-hbcu72cm	39	16	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	39	17	:	:	:
cord-340474-hbcu72cm	39	18	a	a	DT
cord-340474-hbcu72cm	39	19	first	first	JJ
cord-340474-hbcu72cm	39	20	perspective	perspective	NN
cord-340474-hbcu72cm	39	21	Cutaneous	cutaneous	JJ
cord-340474-hbcu72cm	39	22	manifestations	manifestation	NNS
cord-340474-hbcu72cm	39	23	of	of	IN
cord-340474-hbcu72cm	39	24	the	the	DT
cord-340474-hbcu72cm	39	25	Coronavirus	Coronavirus	NNP
cord-340474-hbcu72cm	39	26	Disease	Disease	NNP
cord-340474-hbcu72cm	39	27	2019	2019	CD
cord-340474-hbcu72cm	39	28	(	(	-LRB-
cord-340474-hbcu72cm	39	29	COVID-19	covid-19	NN
cord-340474-hbcu72cm	39	30	)	)	-RRB-
cord-340474-hbcu72cm	40	1	:	:	:
cord-340474-hbcu72cm	40	2	A	a	DT
cord-340474-hbcu72cm	40	3	brief	brief	JJ
cord-340474-hbcu72cm	40	4	review	review	NN
cord-340474-hbcu72cm	40	5	Classification	classification	NN
cord-340474-hbcu72cm	40	6	of	of	IN
cord-340474-hbcu72cm	40	7	the	the	DT
cord-340474-hbcu72cm	40	8	cutaneous	cutaneous	JJ
cord-340474-hbcu72cm	40	9	manifestations	manifestation	NNS
cord-340474-hbcu72cm	40	10	of	of	IN
cord-340474-hbcu72cm	40	11	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	40	12	:	:	:
cord-340474-hbcu72cm	40	13	a	a	DT
cord-340474-hbcu72cm	40	14	rapid	rapid	JJ
cord-340474-hbcu72cm	40	15	prospective	prospective	JJ
cord-340474-hbcu72cm	40	16	nationwide	nationwide	JJ
cord-340474-hbcu72cm	40	17	consensus	consensus	NN
cord-340474-hbcu72cm	40	18	study	study	NN
cord-340474-hbcu72cm	40	19	in	in	IN
cord-340474-hbcu72cm	40	20	Spain	Spain	NNP
cord-340474-hbcu72cm	40	21	with	with	IN
cord-340474-hbcu72cm	40	22	375	375	CD
cord-340474-hbcu72cm	40	23	cases	case	NNS
cord-340474-hbcu72cm	40	24	This	this	DT
cord-340474-hbcu72cm	40	25	article	article	NN
cord-340474-hbcu72cm	40	26	is	be	VBZ
cord-340474-hbcu72cm	40	27	protected	protect	VBN
cord-340474-hbcu72cm	40	28	by	by	IN
cord-340474-hbcu72cm	40	29	copyright	copyright	NN
cord-340474-hbcu72cm	40	30	.	.	.
cord-340474-hbcu72cm	41	1	All	all	DT
cord-340474-hbcu72cm	41	2	rights	right	NNS
cord-340474-hbcu72cm	41	3	reserved	reserve	VBN
cord-340474-hbcu72cm	41	4	SARS	SARS	NNP
cord-340474-hbcu72cm	41	5	-	-	HYPH
cord-340474-hbcu72cm	41	6	Coronavirus-2	Coronavirus-2	NNP
cord-340474-hbcu72cm	41	7	and	and	CC
cord-340474-hbcu72cm	41	8	acute	acute	JJ
cord-340474-hbcu72cm	41	9	urticaria	urticaria	NN
cord-340474-hbcu72cm	41	10	Acute	acute	JJ
cord-340474-hbcu72cm	41	11	urticaria	urticaria	NN
cord-340474-hbcu72cm	41	12	with	with	IN
cord-340474-hbcu72cm	41	13	pyrexia	pyrexia	NN
cord-340474-hbcu72cm	41	14	as	as	IN
cord-340474-hbcu72cm	41	15	the	the	DT
cord-340474-hbcu72cm	41	16	first	first	JJ
cord-340474-hbcu72cm	41	17	manifestations	manifestation	NNS
cord-340474-hbcu72cm	41	18	of	of	IN
cord-340474-hbcu72cm	41	19	a	a	DT
cord-340474-hbcu72cm	41	20	COVID-19	covid-19	CD
cord-340474-hbcu72cm	41	21	infection	infection	NN
cord-340474-hbcu72cm	41	22	Urticaria	Urticaria	NNP
cord-340474-hbcu72cm	41	23	in	in	IN
cord-340474-hbcu72cm	41	24	a	a	DT
cord-340474-hbcu72cm	41	25	patient	patient	NN
cord-340474-hbcu72cm	41	26	with	with	IN
cord-340474-hbcu72cm	41	27	COVID-19	covid-19	NN
cord-340474-hbcu72cm	41	28	:	:	:
cord-340474-hbcu72cm	41	29	Therapeutic	therapeutic	JJ
cord-340474-hbcu72cm	41	30	and	and	CC
cord-340474-hbcu72cm	41	31	diagnostic	diagnostic	JJ
cord-340474-hbcu72cm	41	32	difficulties	difficulty	NNS
cord-340474-hbcu72cm	42	1	Comment	comment	VB
cord-340474-hbcu72cm	42	2	on	on	IN
cord-340474-hbcu72cm	42	3	:	:	:
cord-340474-hbcu72cm	43	1	Cutaneous	cutaneous	JJ
cord-340474-hbcu72cm	43	2	manifestations	manifestation	NNS
cord-340474-hbcu72cm	43	3	in	in	IN
cord-340474-hbcu72cm	43	4	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	43	5	:	:	:
cord-340474-hbcu72cm	43	6	a	a	DT
cord-340474-hbcu72cm	43	7	first	first	JJ
cord-340474-hbcu72cm	43	8	perspective	perspective	NN
cord-340474-hbcu72cm	43	9	.	.	.
cord-340474-hbcu72cm	44	1	Safety	safety	NN
cord-340474-hbcu72cm	44	2	concerns	concern	NNS
cord-340474-hbcu72cm	44	3	of	of	IN
cord-340474-hbcu72cm	44	4	clinical	clinical	JJ
cord-340474-hbcu72cm	44	5	images	image	NNS
cord-340474-hbcu72cm	44	6	and	and	CC
cord-340474-hbcu72cm	44	7	skin	skin	NN
cord-340474-hbcu72cm	44	8	biopsies	biopsy	NNS
cord-340474-hbcu72cm	44	9	Complement	complement	VBP
cord-340474-hbcu72cm	44	10	associated	associate	VBD
cord-340474-hbcu72cm	44	11	microvascular	microvascular	JJ
cord-340474-hbcu72cm	44	12	injury	injury	NN
cord-340474-hbcu72cm	44	13	and	and	CC
cord-340474-hbcu72cm	44	14	thrombosis	thrombosis	NN
cord-340474-hbcu72cm	44	15	in	in	IN
cord-340474-hbcu72cm	44	16	the	the	DT
cord-340474-hbcu72cm	44	17	pathogenesis	pathogenesis	NN
cord-340474-hbcu72cm	44	18	of	of	IN
cord-340474-hbcu72cm	44	19	severe	severe	JJ
cord-340474-hbcu72cm	44	20	COVID-19	covid-19	JJ
cord-340474-hbcu72cm	44	21	infection	infection	NN
cord-340474-hbcu72cm	44	22	:	:	:
cord-340474-hbcu72cm	44	23	A	a	DT
cord-340474-hbcu72cm	44	24	report	report	NN
cord-340474-hbcu72cm	44	25	of	of	IN
cord-340474-hbcu72cm	44	26	five	five	CD
cord-340474-hbcu72cm	44	27	cases	case	NNS
cord-340474-hbcu72cm	45	1	The	the	DT
cord-340474-hbcu72cm	45	2	Role	role	NN
cord-340474-hbcu72cm	45	3	of	of	IN
cord-340474-hbcu72cm	45	4	Cytokines	Cytokines	NNPS
cord-340474-hbcu72cm	45	5	including	include	VBG
cord-340474-hbcu72cm	45	6	Interleukin-6	Interleukin-6	NNP
cord-340474-hbcu72cm	45	7	in	in	IN
cord-340474-hbcu72cm	45	8	COVID-19	COVID-19	NNP
cord-340474-hbcu72cm	45	9	induced	induce	VBN
cord-340474-hbcu72cm	45	10	Pneumonia	Pneumonia	NNP
cord-340474-hbcu72cm	45	11	and	and	CC
cord-340474-hbcu72cm	45	12	Macrophage	Macrophage	NNP
cord-340474-hbcu72cm	45	13	Activation	Activation	NNP
cord-340474-hbcu72cm	45	14	Syndrome	Syndrome	NNP
cord-340474-hbcu72cm	46	1	-Like	-Like	NNP
cord-340474-hbcu72cm	46	2	Disease	Disease	NNP
cord-340474-hbcu72cm	47	1	This	this	DT
cord-340474-hbcu72cm	47	2	article	article	NN
cord-340474-hbcu72cm	47	3	is	be	VBZ
cord-340474-hbcu72cm	47	4	protected	protect	VBN
cord-340474-hbcu72cm	47	5	by	by	IN
cord-340474-hbcu72cm	47	6	copyright	copyright	NN
cord-340474-hbcu72cm	47	7	.	.	.
cord-340474-hbcu72cm	48	1	All	all	DT
cord-340474-hbcu72cm	48	2	rights	right	NNS
cord-340474-hbcu72cm	48	3	reserved	reserve	VBN
cord-340474-hbcu72cm	48	4	.	.	.
cord-340474-hbcu72cm	49	1	Service	service	NN
cord-340474-hbcu72cm	49	2	.	.	.
cord-340474-hbcu72cm	50	1	Accessed	Accessed	NNP
cord-340474-hbcu72cm	50	2	June	June	NNP
cord-340474-hbcu72cm	50	3	7	7	CD
cord-340474-hbcu72cm	50	4	,	,	,
cord-340474-hbcu72cm	50	5	2020	2020	CD
cord-340474-hbcu72cm	50	6	.	.	.
cord-340474-hbcu72cm	51	1	https://www.sps.nhs.uk/articles/summary-of-covid-19medicines-guidance-skin-disorders/	https://www.sps.nhs.uk/articles/summary-of-covid-19medicines-guidance-skin-disorders/	ADD
cord-340474-hbcu72cm	52	1	This	this	DT
cord-340474-hbcu72cm	52	2	article	article	NN
cord-340474-hbcu72cm	52	3	is	be	VBZ
cord-340474-hbcu72cm	52	4	protected	protect	VBN
cord-340474-hbcu72cm	52	5	by	by	IN
cord-340474-hbcu72cm	52	6	copyright	copyright	NN
cord-340474-hbcu72cm	52	7	.	.	.
cord-340474-hbcu72cm	53	1	All	all	DT
cord-340474-hbcu72cm	53	2	rights	right	NNS
cord-340474-hbcu72cm	53	3	reserved.2	reserved.2	NNS
cord-340474-hbcu72cm	53	4	.	.	.
cord-340474-hbcu72cm	54	1	In	in	IN
cord-340474-hbcu72cm	54	2	patients	patient	NNS
cord-340474-hbcu72cm	54	3	with	with	IN
cord-340474-hbcu72cm	54	4	refractory	refractory	JJ
cord-340474-hbcu72cm	54	5	urticaria	urticaria	NN
cord-340474-hbcu72cm	54	6	and/or	and/or	CC
cord-340474-hbcu72cm	54	7	atypical	atypical	JJ
cord-340474-hbcu72cm	54	8	morphology	morphology	NN
cord-340474-hbcu72cm	54	9	,	,	,
cord-340474-hbcu72cm	54	10	the	the	DT
cord-340474-hbcu72cm	54	11	decision	decision	NN
cord-340474-hbcu72cm	54	12	to	to	TO
cord-340474-hbcu72cm	54	13	perform	perform	VB
cord-340474-hbcu72cm	54	14	skin	skin	NN
cord-340474-hbcu72cm	54	15	biopsy	biopsy	NN
cord-340474-hbcu72cm	54	16	and	and	CC
cord-340474-hbcu72cm	54	17	histopathological	histopathological	JJ
cord-340474-hbcu72cm	54	18	examination	examination	NN
cord-340474-hbcu72cm	54	19	can	can	MD
cord-340474-hbcu72cm	54	20	be	be	VB
cord-340474-hbcu72cm	54	21	individualised.3	individualised.3	NNS
cord-340474-hbcu72cm	54	22	.	.	.
cord-340474-hbcu72cm	55	1	For	for	IN
cord-340474-hbcu72cm	55	2	symptomatic	symptomatic	JJ
cord-340474-hbcu72cm	55	3	management	management	NN
cord-340474-hbcu72cm	55	4	of	of	IN
cord-340474-hbcu72cm	55	5	urticaria	urticaria	NN
cord-340474-hbcu72cm	55	6	,	,	,
cord-340474-hbcu72cm	55	7	standard	standard	JJ
cord-340474-hbcu72cm	55	8	doses	dose	NNS
cord-340474-hbcu72cm	55	9	of	of	IN
cord-340474-hbcu72cm	55	10	potent	potent	JJ
cord-340474-hbcu72cm	55	11	,	,	,
cord-340474-hbcu72cm	55	12	second	second	JJ
cord-340474-hbcu72cm	55	13	-	-	HYPH
cord-340474-hbcu72cm	55	14	generation	generation	NN
cord-340474-hbcu72cm	55	15	,	,	,
cord-340474-hbcu72cm	55	16	non	non	JJ
cord-340474-hbcu72cm	55	17	-	-	JJ
cord-340474-hbcu72cm	55	18	sedating	sedating	JJ
cord-340474-hbcu72cm	55	19	H1	h1	NN
cord-340474-hbcu72cm	55	20	antihistamines	antihistamine	NNS
cord-340474-hbcu72cm	55	21	(	(	-LRB-
cord-340474-hbcu72cm	55	22	e.g.	e.g.	RB
cord-340474-hbcu72cm	55	23	fexofenadine/	fexofenadine/	CD
cord-340474-hbcu72cm	55	24	levocetrizine	levocetrizine	NNP
cord-340474-hbcu72cm	55	25	)	)	-RRB-
cord-340474-hbcu72cm	55	26	in	in	IN
cord-340474-hbcu72cm	55	27	twice	twice	RB
cord-340474-hbcu72cm	55	28	-	-	HYPH
cord-340474-hbcu72cm	55	29	daily	daily	NN
cord-340474-hbcu72cm	55	30	dosing	dosing	NN
cord-340474-hbcu72cm	55	31	can	can	MD
cord-340474-hbcu72cm	55	32	be	be	VB
cord-340474-hbcu72cm	55	33	used	use	VBN
cord-340474-hbcu72cm	55	34	.	.	.
cord-340474-hbcu72cm	56	1	In	in	IN
cord-340474-hbcu72cm	56	2	non	non	JJ
cord-340474-hbcu72cm	56	3	-	-	NNS
cord-340474-hbcu72cm	56	4	responders	responder	NNS
cord-340474-hbcu72cm	56	5	,	,	,
cord-340474-hbcu72cm	56	6	the	the	DT
cord-340474-hbcu72cm	56	7	dose	dose	NN
cord-340474-hbcu72cm	56	8	can	can	MD
cord-340474-hbcu72cm	56	9	be	be	VB
cord-340474-hbcu72cm	56	10	increased	increase	VBN
cord-340474-hbcu72cm	56	11	upto	upto	IN
cord-340474-hbcu72cm	56	12	four	four	CD
cord-340474-hbcu72cm	56	13	-	-	RB
cord-340474-hbcu72cm	56	14	fold	fold	VB
cord-340474-hbcu72cm	56	15	the	the	DT
cord-340474-hbcu72cm	56	16	recommended	recommend	VBN
cord-340474-hbcu72cm	56	17	dose	dose	NN
cord-340474-hbcu72cm	56	18	(	(	-LRB-
cord-340474-hbcu72cm	56	19	EAACI	EAACI	NNP
cord-340474-hbcu72cm	56	20	guidelines	guideline	NNS
cord-340474-hbcu72cm	56	21	)	)	-RRB-
cord-340474-hbcu72cm	56	22	.	.	.
cord-340474-hbcu72cm	56	23	 	 	_SP